000 | 02367 a2200625 4500 | ||
---|---|---|---|
005 | 20250517222316.0 | ||
264 | 0 | _c20181108 | |
008 | 201811s 0 0 eng d | ||
022 | _a1873-264X | ||
024 | 7 |
_a10.1016/j.jpba.2018.05.052 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aReis, Rafael | |
245 | 0 | 0 |
_aLiquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the EGFR inhibitors afatinib, erlotinib and osimertinib, the ALK inhibitor crizotinib and the VEGFR inhibitor nintedanib in human plasma from non-small cell lung cancer patients. _h[electronic resource] |
260 |
_bJournal of pharmaceutical and biomedical analysis _cSep 2018 |
||
300 |
_a174-183 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Validation Study | ||
650 | 0 | 4 | _aAcrylamides |
650 | 0 | 4 | _aAfatinib |
650 | 0 | 4 | _aAniline Compounds |
650 | 0 | 4 |
_aAntineoplastic Agents _xblood |
650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xblood |
650 | 0 | 4 | _aChromatography, High Pressure Liquid |
650 | 0 | 4 | _aCrizotinib |
650 | 0 | 4 |
_aDrug Monitoring _xmethods |
650 | 0 | 4 | _aDrug Stability |
650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
650 | 0 | 4 |
_aErlotinib Hydrochloride _xblood |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIndoles _xblood |
650 | 0 | 4 | _aLimit of Detection |
650 | 0 | 4 |
_aLung Neoplasms _xblood |
650 | 0 | 4 |
_aPiperazines _xblood |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xblood |
650 | 0 | 4 |
_aPyrazoles _xblood |
650 | 0 | 4 |
_aPyridines _xblood |
650 | 0 | 4 |
_aQuinazolines _xblood |
650 | 0 | 4 |
_aReceptors, Vascular Endothelial Growth Factor _xantagonists & inhibitors |
650 | 0 | 4 | _aReproducibility of Results |
650 | 0 | 4 | _aSensitivity and Specificity |
650 | 0 | 4 | _aTandem Mass Spectrometry |
700 | 1 | _aLabat, Laurence | |
700 | 1 | _aAllard, Marie | |
700 | 1 | _aBoudou-Rouquette, Pascaline | |
700 | 1 | _aChapron, Jeanne | |
700 | 1 | _aBellesoeur, Audrey | |
700 | 1 | _aThomas-Schoemann, Audrey | |
700 | 1 | _aArrondeau, Jennifer | |
700 | 1 | _aGiraud, Frédérique | |
700 | 1 | _aAlexandre, Jérôme | |
700 | 1 | _aVidal, Michel | |
700 | 1 | _aGoldwasser, François | |
700 | 1 | _aBlanchet, Benoît | |
773 | 0 |
_tJournal of pharmaceutical and biomedical analysis _gvol. 158 _gp. 174-183 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jpba.2018.05.052 _zAvailable from publisher's website |
999 |
_c28511976 _d28511976 |